CME Group (NASDAQ:CME) PT Raised to $228.00 at Barclays

CME Group (NASDAQ:CMEGet Free Report) had its target price raised by equities researchers at Barclays from $226.00 to $228.00 in a research report issued to clients and investors on Thursday, Benzinga reports. The firm currently has an “equal weight” rating on the financial services provider’s stock. Barclays‘s target price indicates a potential upside of 8.09% from the stock’s previous close.

A number of other research analysts have also recently issued reports on the stock. Bank of America boosted their price objective on shares of CME Group from $209.00 to $216.00 and gave the company a “neutral” rating in a report on Thursday. Argus boosted their price objective on shares of CME Group from $225.00 to $245.00 and gave the company a “buy” rating in a report on Wednesday, March 6th. Keefe, Bruyette & Woods boosted their price objective on shares of CME Group from $222.00 to $226.00 and gave the company a “market perform” rating in a report on Thursday. Morgan Stanley boosted their price objective on shares of CME Group from $222.00 to $225.00 and gave the company an “equal weight” rating in a report on Tuesday, April 9th. Finally, The Goldman Sachs Group lowered shares of CME Group from a “neutral” rating to a “sell” rating and set a $195.00 price target on the stock. in a research note on Wednesday, January 3rd. Two investment analysts have rated the stock with a sell rating, seven have given a hold rating and two have assigned a buy rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Hold” and an average price target of $217.80.

Read Our Latest Stock Report on CME

CME Group Stock Down 0.8 %

Shares of NASDAQ:CME opened at $210.94 on Thursday. CME Group has a one year low of $175.73 and a one year high of $223.80. The company has a 50 day moving average of $214.73 and a 200-day moving average of $211.90. The company has a debt-to-equity ratio of 0.10, a current ratio of 1.01 and a quick ratio of 1.02. The stock has a market cap of $75.94 billion, a price-to-earnings ratio of 24.00, a P/E/G ratio of 5.97 and a beta of 0.49.

CME Group (NASDAQ:CMEGet Free Report) last issued its quarterly earnings results on Wednesday, April 24th. The financial services provider reported $2.50 EPS for the quarter, topping the consensus estimate of $2.44 by $0.06. CME Group had a net margin of 56.84% and a return on equity of 12.45%. The company had revenue of $1.49 billion during the quarter, compared to analysts’ expectations of $1.48 billion. During the same quarter in the previous year, the company earned $2.42 EPS. CME Group’s revenue was up 3.2% on a year-over-year basis. On average, sell-side analysts forecast that CME Group will post 9.58 earnings per share for the current year.

Hedge Funds Weigh In On CME Group

Institutional investors have recently added to or reduced their stakes in the company. Naples Global Advisors LLC increased its holdings in CME Group by 5.6% during the fourth quarter. Naples Global Advisors LLC now owns 2,072 shares of the financial services provider’s stock worth $436,000 after buying an additional 110 shares during the last quarter. Sapient Capital LLC acquired a new position in shares of CME Group in the fourth quarter valued at $1,823,000. FNY Investment Advisers LLC acquired a new position in shares of CME Group in the fourth quarter valued at $1,074,000. Deutsche Bank AG grew its stake in shares of CME Group by 4.3% in the third quarter. Deutsche Bank AG now owns 1,118,104 shares of the financial services provider’s stock valued at $223,867,000 after acquiring an additional 46,021 shares in the last quarter. Finally, International Assets Investment Management LLC acquired a new position in shares of CME Group in the fourth quarter valued at about $27,986,000. 87.75% of the stock is currently owned by institutional investors and hedge funds.

About CME Group

(Get Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Read More

Analyst Recommendations for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.